ホームページへ

Bone Marrow Transplant for Pediatric Osteosarcoma at Sheba Hospital- JCI accreditated and Top-10 Hospitals 2025 by Newsweek

イスラエル ラマト・ガン
Map
シェバ医療センター
クリニックを見る
5
医師 5.0
スタッフ 5.0
施設 5.0
言語サポート 5.0
サポート 5.0
強く推奨
98%のクライアントがこのクリニックを推奨
17 患者
昨年このクリニックでの治療を選択されました

このパッケージに含まれるもの

医療処置
  • 腫瘍専門医の診察
  • 肉腫診断
  • 骨髄移植術
  • 栄養士による1日3食
  • 24時間看護サービス
  • 心電図(ECG)
  • 血液検査
  • 胸部X線
  • HIV抗体検査
  • B型肝炎コア抗体検査
  • 抗HCV抗体検査
  • 心エコー図検査
  • 全血球計算(CBC)
  • 生化学血液検査
  • PET/CT
  • 腫瘍専門医との診察
  • 免疫専門医への相談
  • 循環器科医への相談
  • 小児血液専門医との相談
  • 小児科医との相談
  • 腫瘍血液専門医との診察
  • 頭部MRI
  • 生検
  • 骨塩定量検査(CBM)
  • 腫瘍マーカーおよび蛋白分画を含む全血球算定
期間
  • 30 日 病院で
宿泊

入院

交通
  • 空港-クリニック-空港間の送迎

追加情報

Bone Marrow Transplant for Pediatric Osteosarcoma

Sheba Medical Center – Advanced, Personalized Transplant Care for Children

At Sheba Medical Center, we understand how difficult it is for families to face a diagnosis of osteosarcoma. As the most common primary bone cancer in children and adolescents, it requires highly specialized, coordinated care and strong support for both the child and their loved ones.

While most children are successfully treated with a combination of chemotherapy and surgery, bone marrow transplantation (BMT) may be considered in selected, more complex cases, offering an advanced treatment approach when additional therapeutic intensity is needed.

Our pediatric transplant program combines leading medical expertise, innovative therapies, and compassionate, family-centered care to support children at every stage of treatment.

When is a Bone Marrow Transplant Needed?

Bone marrow transplantation is not routinely used for all children with osteosarcoma, but may be recommended in specific situations, including:

High-risk disease, particularly when cancer has spread (metastatic osteosarcoma)
Relapsed disease, when osteosarcoma returns after initial treatment
Cases where a more intensive treatment strategy is appropriate

In these settings, BMT allows doctors to deliver high-dose chemotherapy to target cancer cells, followed by the infusion of healthy stem cells to restore bone marrow and support recovery.

Types of Transplant
Autologous Transplant (Child’s Own Cells)

This is the most commonly used transplant approach when BMT is part of osteosarcoma treatment.

Stem cells are collected from the child before intensive therapy
High-dose chemotherapy is administered
The child’s own stem cells are reinfused to rebuild healthy bone marrow

This approach enables delivery of higher-dose treatment while supporting safe recovery.

Allogeneic Transplant (Donor Cells)

In carefully selected cases, Sheba Medical Center also offers allogeneic (donor) transplantation as part of a comprehensive care strategy.

This option may be considered when:

An alternative stem cell source is needed
An immune-based treatment approach may provide additional benefit

Donor options at Sheba include:

Matched sibling donors
Matched unrelated donors from international registries
Haploidentical (half-matched) family donors

A potential advantage of donor transplantation is the graft-versus-tumor effect, where the new immune system may help identify and target remaining cancer cells.

Precision Matching and Advanced Technology

Sheba Medical Center utilizes an advanced on-site HLA laboratory for high-resolution genetic testing, ensuring the most accurate donor matching when needed.

This precision enhances safety and supports optimal transplant outcomes.

Advanced Pediatric Osteosarcoma Care

Care at Sheba is highly coordinated and tailored to each child:

Integration of chemotherapy, surgery, and transplant strategies
Access to innovative and emerging therapies
Close collaboration between pediatric oncologists, orthopedic surgeons, and transplant specialists
Comprehensive supportive care throughout treatment
Specialized Pediatric Transplant Environment

Children receiving BMT are treated in dedicated pediatric transplant units designed for safety and comfort:

Child-friendly, highly protected environments
Advanced infection prevention systems
Continuous care by experienced pediatric specialists

Every aspect of care is adapted to support children physically and emotionally.

Clinical Expertise

Sheba Medical Center is a leading center for pediatric oncology and transplantation, offering:

Experience in treating complex and high-risk osteosarcoma cases
Expertise in high-dose therapy with stem cell support
Outcomes aligned with leading international centers
Long-term follow-up focused on growth, recovery, and quality of life

Care That Supports the Whole Family

We understand that this journey affects the entire family.

At Sheba, children and their families are supported by a multidisciplinary team including physicians, nurses, psychologists, and care coordinators—ensuring guidance, reassurance, and continuous support throughout treatment.

Why Families Choose Sheba for Pediatric BMT

Leading pediatric transplant center
Expertise in complex bone tumors
Access to a wide range of donor options
Advanced technologies and treatment approaches
Compassionate, child-centered care
Dedicated international patient services

A Message of Hope

At Sheba Medical Center, we combine advanced science with compassionate care to give every child the best possible chance for recovery. Even in complex cases like osteosarcoma, we are committed to supporting families with strength, clarity, and hope every step of the way.

24時間年中無休Bookimedサポート
  • 専任医療コーディネーター
  • 医療旅行手配 — 特別パートナー価格での航空券・ホテル予約
  • 医療旅行中の患者擁護

プログラム料金

$160,000

このパッケージに含まれないもの

航空運賃
ホテル
含まれない追加活動

医師

Hana Golan
Hematologist
24年の経験
委員会認定プロフェッショナル

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

続きを読む
医師プロフィールを見る

調子はいかがですか?

1 の 3
このプログラムの情報は完全で明確です
1
2
3
4
5
強く反対
強く賛成

クリニックについて

すべての写真を表示
シェバ医療センター

シェバ医療センターはイスラエルおよび世界有数の病院の一つです。 ニューズウィーク・インターナショナル誌は、Sheba Hospitalを2020年の世界トップ10病院にランク付けしました。同病院は1,990の専門分野をカバーしており、毎年世界中から1,500,000人を超える患者がシェバ病院を受診しています。

支払い・特典

当社サービスへのお支払いはありません

クリニックで直接またはその公式銀行口座にお支払いいただきます。

安全な予約

一部のクリニックでは保証金が必要な場合があります。

柔軟な分割払い

分割払いオプションでお支払いを分散してください。

紹介プログラム

Bookimedにお友達を紹介して報酬を獲得してください。

所在地
Derech Sheba 2, Ramat Gan, Israel

なぜ皆様に愛されるのか

こちらもお気に入りかもしれません

$160,000
パッケージあたり
5.0
2 レビュー